Clinical Trial Update: Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating encapsulated rapamycin (eRapa) for prevention of non-muscle invasive bladder cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Sirolimus (Rapamycin) (sirolimus)

Snippet

Sponsor: Robert Svatek | Conditions: Non-muscle Invasive Bladder Cancer | Phase 2 | Status: RECRUITING